Condition
Coronary Microvascular Dysfunction (CMD) clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Coronary Microvascular Dysfunction (CMD) clinical trials that are recruiting, at sites in 8 countries (most in United States (3), United Kingdom (2), Ireland (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 8Countries
Newest Coronary Microvascular Dysfunction (CMD) clinical trials
All recruiting trials (8)
-
Women with chest pain and non-obstructive arteries: personalized diagnostic and treatment approach
This study tests a personalized diagnostic-and-treatment pathway for women with angina but non-obstructive coronary arteries to see if targeted therapy improves symptoms and quality of life.
-
Multi-sensor wireless pressure catheter to test microvascular function in people with angina and non-obstructive arteries
Doctors are testing a new wireless pressure catheter to see if it can accurately diagnose coronary microvascular dysfunction in people with angina but non-obstructive arteries, using MRI perfusion as the reference test.
-
How kidney transplant affects blood flow in the heart's tiny vessels in people with advanced CKD
This study will try to see if getting a kidney transplant improves blood flow in the small vessels of the heart for people with advanced chronic kidney disease who are on the transplant waitlist.
-
Nitrate Beetroot Juice to Help Blood Flow in Women with ANOCA and CMD
We’re testing whether nitrate-rich beetroot juice for 14 days can improve heart blood flow and quality of life for women with ANOCA and CMD compared with a placebo.
-
Personalized exercise and dietary program for patients with microvascular coronary dysfunction
This study is testing a personalized exercise and diet program to see if it helps people with microvascular coronary dysfunction feel better and manage their symptoms.
-
Improving heart blood flow and angina in women using an SGLT2 pill (STRONG)
This trial will test whether taking the SGLT2 pill Brezavvy for 12 weeks can improve coronary microvascular blood flow and reduce angina symptoms in women with non-obstructive coronary artery disease.
-
Registry for patients with non-obstructive coronary artery disease
This study looks at people with non-obstructive coronary artery disease to see how common chest pain is and if personalized treatments can improve their symptoms and overall health over five years.
-
Stratified medicine approach for managing angina without obstructive coronary artery disease
This study is testing if a personalized treatment plan based on a special heart test can help people with angina who don’t have blocked arteries feel better and improve their health.
Related topics
Quick answers
How many Coronary Microvascular Dysfunction (CMD) clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (3 trials), United Kingdom (2 trials), Ireland (1 trial), Netherlands (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.